# A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}

Study · id `cardio:ct-nct02358343` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02358343](<https://clinicaltrials.gov/study/NCT02358343>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02358343

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

## Technical summary

Registry record NCT02358343. Randomized; no masking; primary purpose treatment. Start 2015-03-23 (actual); primary completion 2017-11-15 (actual). Results posted on 2019-07-23.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 184 participants (enrolled count; ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Started: 2015-03-23 (actual) (ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Primary completion: 2017-11-15 (actual) (ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Completion: 2017-12-15 (actual) (ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Results first posted: 2019-07-23 (ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02358343, source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02358343-2019-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
- Acronym: ASCEND
- Condition: Depression
- Condition: End Stage Renal Disease
- Intervention (Behavioral): Engagement Interview
- Intervention (Behavioral): Cognitive Behavioral Therapy
- Intervention (Drug): Antidepressant Drug Therapy
- Lead sponsor: University of Washington
- Lead sponsor class: OTHER
- Collaborator: University of Texas
- Collaborator class: OTHER
- Collaborator: University of New Mexico
- Collaborator class: OTHER
- Collaborator: Patient-Centered Outcomes Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Washington (`cardio:org-university-of-washington`)
- Registry lists this organization as a collaborator: University of Texas (`cardio:org-university-of-texas`)
- Registry lists this organization as a collaborator: University of New Mexico (`cardio:org-university-of-new-mexico`)
- Registry lists this organization as a collaborator: Patient-Centered Outcomes Research Institute (`cardio:org-patient-centered-outcomes-research-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial (`cardio:pubmed-30802897`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: dc343075333d6f06e823a1557c56545f14a3eb15ce017024ba79d2f65712f28d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
